161 related articles for article (PubMed ID: 34513881)
1. Coagulation and Fibrinolysis Biomarkers as Potential Indicators for the Diagnosis and Classification of Ovarian Hyperstimulation Syndrome.
Li S; Qian Y; Pei Y; Wu K; Lu S
Front Med (Lausanne); 2021; 8():720342. PubMed ID: 34513881
[No Abstract] [Full Text] [Related]
2. Changes of new coagulation markers in healthy pregnant women and establishment of reference intervals in Changsha.
Yang Y; Hu Y; Wu M; Xiang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):469-478. PubMed ID: 35545342
[TBL] [Abstract][Full Text] [Related]
3. Trimester-specific reference intervals of TAT, TM, tPAI-C and PIC for healthy Chinese pregnant women.
Wu Y; Qiao Y; Zhang Y; Li Q; Zhang W
J Obstet Gynaecol Res; 2021 Jan; 47(1):368-374. PubMed ID: 33345424
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
[TBL] [Abstract][Full Text] [Related]
5. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
Mei H; Jiang Y; Luo L; Huang R; Su L; Hou M; Wang X; Deng J; Hu Y
Thromb Res; 2019 Jan; 173():20-26. PubMed ID: 30458338
[TBL] [Abstract][Full Text] [Related]
6. Performance evaluation of thrombomodulin, thrombin-antithrombin complex, plasmin-α2-antiplasmin complex, and t-PA: PAI-1 complex.
Chen Q; Shou W; Wu W; Wang G; Cui W
J Clin Lab Anal; 2019 Jul; 33(6):e22913. PubMed ID: 31090232
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms.
Huang K; Mo Q; Liao C; Feng S; Liu G; Jiang D; Lei P
Clin Exp Med; 2024 May; 24(1):107. PubMed ID: 38776019
[TBL] [Abstract][Full Text] [Related]
8. Clinical Impact of Coagulation and Fibrinolysis Markers for Predicting Postoperative Venous Thromboembolism in Total Joint Arthroplasty Patients.
Cheng Y; Liu J; Su Y; Zhao H; Zhao Y; Wen M; Lu S; Zhang W; Wu J
Clin Appl Thromb Hemost; 2019; 25():1076029619877458. PubMed ID: 31608652
[TBL] [Abstract][Full Text] [Related]
9. Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study.
Wang L; Zhong J; Xiao D; Huang W; Zheng Z; Jiang Y
Ann Transl Med; 2022 Dec; 10(23):1273. PubMed ID: 36618792
[TBL] [Abstract][Full Text] [Related]
10. Automated measurement of coagulation and fibrinolytic activation markers: Outcomes in coronavirus disease 2019 (COVID-19) patients.
Gardiner C; Mackie IJ; MacCallum P; Platton S
Int J Lab Hematol; 2022 Oct; 44(5):817-822. PubMed ID: 35451557
[TBL] [Abstract][Full Text] [Related]
11. Identification of soluble thrombomodulin and tissue plasminogen activator-inhibitor complex as biomarkers for prognosis and early evaluation of septic shock and sepsis-induced disseminated intravascular coagulation.
Zhang J; Xue M; Chen Y; Liu C; Kuang Z; Mu S; Wei W; Yin J; Xiang H; Hu Y; Long X; Fang S; Sun S; Wang B; Tong C; Song Z
Ann Palliat Med; 2021 Oct; 10(10):10170-10184. PubMed ID: 34551574
[TBL] [Abstract][Full Text] [Related]
12. Performance evaluation of thrombus molecular markers thrombomodulin, thrombin-antithrombin complex, plasmin-α2-plasmin inhibitor complex, and tissue plasminogen activator-inhibitor complex by a chemiluminescence analyzer.
Lirong T; Minmin X; Manqiu Y; Yanping L
Hippokratia; 2022; 26(2):78-82. PubMed ID: 37188051
[TBL] [Abstract][Full Text] [Related]
13. Trimester-specific reference intervals of hemostasis biomarkers for healthy pregnancy.
Xiao H; Yu W; Li L; Yin X; Zhai Q; Hu D; Zhang X; Wang F
Scand J Clin Lab Invest; 2023 Oct; 83(6):379-383. PubMed ID: 37491076
[TBL] [Abstract][Full Text] [Related]
14. Significance of coagulation and fibrinolysis markers for benign and malignant soft tissue tumors.
Asanuma K; Nakamura T; Hagi T; Okamoto T; Kita K; Nakamura K; Matsuyama Y; Yoshida K; Asanuma Y; Sudo A
BMC Cancer; 2021 Apr; 21(1):364. PubMed ID: 33827473
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Coagulation, Fibrinolysis and Endothelial Biomarkers in Cirrhotic Patients With or Without Portal Venous Thrombosis.
Ren W; Zhang J; Chen Y; Wen M; Su Y; Zhao Y; Lu S; Wu J
Clin Appl Thromb Hemost; 2020; 26():1076029620982666. PubMed ID: 33356499
[TBL] [Abstract][Full Text] [Related]
16. Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis.
Li J; Zhou J; Ren H; Teng T; Li B; Wang Y; Xiang L
Clin Appl Thromb Hemost; 2022; 28():10760296221102929. PubMed ID: 35603624
[TBL] [Abstract][Full Text] [Related]
17. Clinical study on the feasibility of new thrombus markers in predicting massive cerebral infarction.
Zhao X; Yang S; Lei R; Duan Q; Li J; Meng J; Sun L
Front Neurol; 2022; 13():942887. PubMed ID: 36761916
[TBL] [Abstract][Full Text] [Related]
18. Value of TAT and PIC with D-dimer for cancer patients with metastasis.
Cui C; Gao J; Li J; Yu M; Zhang H; Cui W
Int J Lab Hematol; 2020 Aug; 42(4):387-393. PubMed ID: 32250048
[TBL] [Abstract][Full Text] [Related]
19. A performance evaluation of chemiluminescence enzyme immunoassays on the Sysmex CN-6500 haemostasis analyser.
Gardiner C; Lane P; Tailor H; Machin SJ; Mackie IJ
Int J Lab Hematol; 2021 Dec; 43(6):1593-1598. PubMed ID: 34252265
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of coagulation markers in patients with colorectal caner: A prospective study.
Chen W; Li Y; Wang W; Xue Y; Qian J; Liu W; Hu X
Health Sci Rep; 2024 Feb; 7(2):e1553. PubMed ID: 38304067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
